Street Calls of the Week
General Atlantic, L.P., a major shareholder in Alignment Healthcare, Inc. (NASDAQ:ALHC), sold 13,460,000 shares of common stock on September 12, 2025. The shares were sold at a price of $16.01, with the transaction amounting to $215,494,600. The sale comes amid ALHC’s strong year-to-date performance, with shares up 45% according to InvestingPro data.
Following the transaction, General Atlantic’s direct and indirect ownership in Alignment Healthcare stands at 30,842,175 shares. The shares were sold by General Atlantic (ALN HLTH), L.P.
General Atlantic, L.P. maintains it is a director-by-deputization solely for purposes of Section 16 of the Exchange Act.
In other recent news, Alignment Healthcare reported its second-quarter 2025 earnings, which significantly exceeded expectations. The company posted an earnings per share of $0.07, surpassing the forecast of -$0.07, and achieved a revenue of $1 billion, outperforming the anticipated $960.51 million. These results highlight strong business growth and performance. Following the earnings report, Barclays upgraded Alignment Healthcare’s stock from Underweight to Equalweight, raising its price target from $9.00 to $13.00. The upgrade was influenced by the company’s revenue being 6% above forecasts and EBITDA $32 million higher than anticipated. Additionally, KeyBanc upgraded the company’s stock to Overweight, citing Alignment Healthcare’s improved hospital utilization and effective reinvestment of savings into member benefits. Moreover, the company announced the appointment of Matt Eyles as executive vice president of government strategy, a newly created position aimed at enhancing healthcare policy engagement and business planning. These developments reflect Alignment Healthcare’s strategic efforts to strengthen its market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.